E. Heidemann
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer survivorship and care, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)(2005)573 cited
- → Randomized phase II study of single-agent epirubicin +/— verapamil in patients with advanced metastatic breast cancer(1993)51 cited
- → Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial(2002)49 cited
- → Primary breast cancer therapy in six regions of Germany(2002)46 cited
- → Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial).(2009)43 cited
- → Tumorpatienten in Deutschland: Was wissen wir über Schmerzprävalenzen?(1999)35 cited
- → Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial(2016)33 cited
- → Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.(2009)31 cited
- → Mitoxantrone in the treatment of relapsed and refractory acute leukemia(1985)30 cited
- → Randomized Clinical Trial Comparing Mitoxantrone with Epirubicin and with Doxorubicin, each Combined with Cyclophosphamide in the First-Line Treatment of Patients with Metastatic Breast Cancer(1990)29 cited